Bausch & Lomb 1999 Annual Report

Business Segment The following table presents sales and other financial information by business segment for the years 1999, 1998 and 1997.
The company does not have material intersegment sales.
Operating Depreciation Capital
Net Sales Earnings and Amortization Expenditures Assets
1999
Vision Care $1,029.5 $200.5 $ 65.3 $ 54.5 $ 524.3
Pharmaceuticals 293.9 66.1 16.0 21.1 266.4
Surgical 432.7 64.1 41.4 18.3 769.3
1,756.1 330.7 122.7 93.9 1,560.0
Corporate administration .– (63.0) 6.5 43.4 1,246.0
Restructuring1 .– (53.5) .– .– .–
Discontinued assets .– .– 27.0 18.6 .–
Net assets held for disposal .– .– .– .– 29.3
Amounts not allocated .– .– .– .– 438.2
$1,756.1 $214.2 $156.2 $155.9 $3,273.5
1998
Vision Care $ 971.2 $208.4 $ 62.8 $112.8 $ 555.3
Pharmaceuticals 241.6 49.2 15.6 17.2 262.2
Surgical 384.7 43.0 36.6 14.5 696.3
1,597.5 300.6 115.0 144.5 1,513.8
Corporate administration .– (52.6) 2.7 18.7 448.8
Restructuring2 .– (5.4) .– .– .–
Other significant charges3 .– (73.1) .– .– .–
Discontinued assets .– .– 46.1 38.3 657.9
Amounts not allocated .– .– .– .– 871.2
$1,597.5 $169.5 $163.8 $201.5 $3,491.7
1997
Vision Care $ 918.1 $210.9 $ 49.0 $ 73.6 $ 463.1
Pharmaceuticals 190.6 36.6 10.9 10.0 192.5
1,108.7 247.5 59.9 83.6 655.6
Corporate administration .– (45.5) 2.2 1.6 456.0
Restructuring4 .– (39.1) .– .– .–
Discontinued assets .– .– 49.9 40.9 817.4
Amounts not allocated .– .– .– .– 843.9
$1,108.7 $162.9 $112.0 $126.1 $2,772.9
1 Restructuring charges and asset write-offs were recorded as follows: vision care, $52.9; pharmaceuticals, $2.0; corporate administration, $1.8 and a reversal of $3.2 related to
the 1997 reserve.
2 Restructuring charges and asset write-offs were recorded as follows: vision care, $2.3 and corporate administration, $3.1.
3 Other significant charges consisted of a charge of $41.0 for purchased in-process R&D and a purchase accounting inventory adjustment of $32.1. Both adjustments related to
the Chiron Vision and Storz acquisitions.
4 Restructuring charges and asset write-offs were recorded as follows: vision care, $19.4; pharmaceuticals, $5.0; and corporate administration, $14.7.
See the future 31 Bausch & Lomb